Samuel S.K. Lam
NeoPhotonics (United States)(US)St Mary's University College(GB)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Nanoplatforms for cancer theranostics, Photodynamic Therapy Research Studies, Cancer Immunotherapy and Biomarkers, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens(2014)1,964 cited
- → Compensatory dendritic cell development mediated by BATF–IRF interactions(2012)408 cited
- → Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice(2010)159 cited
- → Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCγ2 signaling axis in mice(2007)123 cited
- → InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity(2015)79 cited
- → An ITAM-signaling pathway controls cross-presentation of particulate but not soluble antigens in dendritic cells(2007)67 cited
- → N-dihydrogalactochitosan as immune and direct antitumor agent amplifying the effects of photodynamic therapy and photodynamic therapy-generated vaccines(2019)36 cited
- → Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy(2021)30 cited
- → Single‐cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing(2022)24 cited
- → N‐dihydrogalactochitosan as a potent immune activator for dendritic cells(2016)24 cited